{"id":"https://openalex.org/W4243456550","doi":"https://doi.org/10.1517/13543776.10.3.279","title":"Vaccines adjuvants","display_name":"Vaccines adjuvants","publication_year":2000,"publication_date":"2000-03-01","ids":{"openalex":"https://openalex.org/W4243456550","doi":"https://doi.org/10.1517/13543776.10.3.279"},"language":"en","primary_location":{"id":"doi:10.1517/13543776.10.3.279","doi":"https://doi.org/10.1517/13543776.10.3.279","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543776.10.3.279","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088019995","display_name":"Mark J. Newman","orcid":"https://orcid.org/0000-0002-0433-6690","observed_orcids":["https://orcid.org/0000-0002-0433-6690"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mark J Newman","raw_affiliation_strings":["Infectious Disease Program, Epimmune, Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121, USA. mnewman@epimmune.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Program, Epimmune, Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121, USA. mnewman@epimmune.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5088019995"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1193,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.51723708,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"10","issue":"3","first_page":"279","last_page":"314"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.996999979019165},{"id":"https://openalex.org/keywords/aluminum-salts","display_name":"aluminum salts","score":0.7429999709129333},{"id":"https://openalex.org/keywords/plant-saponins","display_name":"plant saponins","score":0.8379999995231628},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.8849999904632568},{"id":"https://openalex.org/keywords/synthetic-polymers","display_name":"synthetic polymers","score":0.984000027179718},{"id":"https://openalex.org/keywords/hiv-1-vaccine","display_name":"HIV-1 vaccine","score":0.8029999732971191},{"id":"https://openalex.org/keywords/immunocompromised-populations","display_name":"immunocompromised populations","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.6269999742507935},{"id":"https://openalex.org/keywords/vaccine-efficacy","display_name":"vaccine efficacy","score":0.414000004529953},{"id":"https://openalex.org/keywords/adjuvant-toxicity","display_name":"adjuvant toxicity","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.8555222153663635},{"id":"https://openalex.org/C3020289777","wikidata":"https://www.wikidata.org/wiki/Q967453","display_name":"Vaccine adjuvant","level":3,"score":0.6348059773445129},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5116525292396545},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41045624017715454},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4017288386821747},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3212607502937317},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3128286600112915},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1517/13543776.10.3.279","doi":"https://doi.org/10.1517/13543776.10.3.279","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543776.10.3.279","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W237758694","https://openalex.org/W1564933160","https://openalex.org/W1619931878","https://openalex.org/W1918084043","https://openalex.org/W1922307675","https://openalex.org/W1923224286","https://openalex.org/W1940767994","https://openalex.org/W1947173445","https://openalex.org/W1948221318","https://openalex.org/W1965485518","https://openalex.org/W1966083353","https://openalex.org/W1966094348","https://openalex.org/W1969605397","https://openalex.org/W1970623056","https://openalex.org/W1971270966","https://openalex.org/W1975878941","https://openalex.org/W1976374552","https://openalex.org/W1977432548","https://openalex.org/W1979988802","https://openalex.org/W1982696173","https://openalex.org/W1982752226","https://openalex.org/W1988711597","https://openalex.org/W1990545540","https://openalex.org/W1994102705","https://openalex.org/W2005426040","https://openalex.org/W2005635106","https://openalex.org/W2006025841","https://openalex.org/W2009746224","https://openalex.org/W2013872507","https://openalex.org/W2015465792","https://openalex.org/W2017741517","https://openalex.org/W2020712451","https://openalex.org/W2021917303","https://openalex.org/W2023702014","https://openalex.org/W2025345914","https://openalex.org/W2025372248","https://openalex.org/W2025416962","https://openalex.org/W2029844324","https://openalex.org/W2030408793","https://openalex.org/W2031957719","https://openalex.org/W2033441782","https://openalex.org/W2043619106","https://openalex.org/W2048091022","https://openalex.org/W2050871684","https://openalex.org/W2051532247","https://openalex.org/W2061517625","https://openalex.org/W2064626913","https://openalex.org/W2067749638","https://openalex.org/W2070101126","https://openalex.org/W2074360914","https://openalex.org/W2074913182","https://openalex.org/W2075535116","https://openalex.org/W2076902549","https://openalex.org/W2085952814","https://openalex.org/W2092240421","https://openalex.org/W2094317076","https://openalex.org/W2094868581","https://openalex.org/W2100036661","https://openalex.org/W2101634316","https://openalex.org/W2123896848","https://openalex.org/W2150902623","https://openalex.org/W2152758574","https://openalex.org/W2156918343","https://openalex.org/W2162144034","https://openalex.org/W2227522986","https://openalex.org/W2239850217","https://openalex.org/W2258524519","https://openalex.org/W2326034983","https://openalex.org/W2336659695","https://openalex.org/W2340524139","https://openalex.org/W2468859699","https://openalex.org/W3025036998"],"related_works":["https://openalex.org/W2001337363","https://openalex.org/W1974536984","https://openalex.org/W2018544077","https://openalex.org/W1973942449","https://openalex.org/W2007680956","https://openalex.org/W2623767528","https://openalex.org/W4322621551","https://openalex.org/W2002018327","https://openalex.org/W1572881837","https://openalex.org/W2003055084"],"abstract_inverted_index":{"A":[0],"wide":[1],"variety":[2],"of":[3,73,122,146,153,164,168,186,200,224,236,241],"adjuvant-active":[4],"materials":[5],"have":[6,39,216,261],"been":[7,262],"used":[8,18,116,171,230],"in":[9,41,117,254,264],"experimental":[10],"and":[11,53,96,98,111,182,239],"veterinary":[12],"vaccines":[13,22,127,158,215,256],"but":[14,34],"the":[15,42,58,71,108,144,151,183,201,209,222,237,258],"only":[16],"commonly":[17,173],"adjuvants":[19,103,242],"for":[20,30,69,126,132,157,221,250],"human":[21,74,187],"are":[23,32,79,204,244],"based":[24],"on":[25,107],"aluminium":[26],"salts.":[27],"The":[28,136],"reasons":[29],"this":[31,154,265],"numerous":[33],"most":[35,172,245],"new":[36,77,177],"adjuvant":[37,178],"products":[38,65,78,113,226],"failed":[40],"developmental":[43],"stage":[44],"due":[45],"to":[46,128,138,150,174,197,231,247],"toxicity":[47],"or":[48],"limitations":[49,240],"associated":[50],"with":[51,66],"manufacturing":[52],"stability.":[54],"Research":[55],"completed":[56],"over":[57],"last":[59],"30":[60],"years":[61],"is":[62,148],"now":[63],"providing":[64],"significant":[67,195],"potential":[68],"improving":[70],"efficacy":[72],"vaccines.":[75],"These":[76],"derived":[80],"from":[81],"many":[82,112],"different":[83],"sources,":[84],"including":[85],"natural":[86],"products,":[87],"such":[88,207],"as":[89,208,219,252],"plant":[90],"saponins,":[91],"bacterial":[92],"lipopolysaccharides,":[93],"biodegradable":[94],"oils":[95],"lipids,":[97],"novel":[99],"synthetic":[100],"polymers.":[101],"Individual":[102],"exert":[104],"varied":[105],"effects":[106],"immune":[109],"system":[110],"can":[114,228],"be":[115,129,229,248],"combination":[118],"formulations.":[119],"This":[120],"degree":[121],"flexibility":[123],"will":[124],"allow":[125],"optimally":[130],"formulated":[131],"specific":[133],"disease":[134],"targets.":[135],"ability":[137],"produce":[139],"more":[140],"potent":[141,213],"vaccines,":[142],"through":[143],"use":[145,251],"adjuvants,":[147],"critical":[149],"expansion":[152],"field,":[155],"especially":[156],"targeting":[159],"pathogens":[160],"where":[161],"no":[162],"form":[163],"protection":[165],"exists.":[166],"Examples":[167],"pathogen":[169],"targets":[170],"clinically":[175],"evaluate":[176],"technologies":[179],"include":[180],"HIV-1":[181],"causative":[184],"agent":[185],"malaria,":[188],"Plasmodium":[189],"falciparum.":[190],"Adjuvants":[191],"may":[192],"also":[193],"provide":[194],"benefit":[196],"those":[198],"segments":[199],"population":[202],"that":[203,227,243],"partially":[205],"immunocompromised,":[206],"elderly.":[210],"Finally,":[211],"highly":[212],"adjuvant-supplemented":[214],"shown":[217],"promise":[218],"therapeutics":[220],"treatment":[223],"cancer;":[225],"supplement":[232],"established":[233],"therapies.":[234],"Descriptions":[235],"advantages":[238],"likely":[246],"available":[249],"components":[253],"licensed":[255],"within":[257],"next":[259],"decade":[260],"included":[263],"review.":[266]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2022-05-12T00:00:00"}